info@trustbridge-compliance.com
Independent digital-quality & AI validation advisory

I help pharma quality teams make their systems, and their AI, inspection-ready.

Senior-led validation, CSV to CSA transformation and AI governance for pharma, biotech and CDMO. 25 years of doing the work, and teaching teams to run it.

25+
years in pharma quality IT
Annex 22
industry reviewer, EU GMP AI draft
300+
inspections supported, zero critical findings
40+
sites gone paperless
The journey

I walk the whole road with you

Not a report and a goodbye. Train the team, set up the quality system, implement, then stay close while it runs.

The AI journey

You have the AI tools. You have the use cases. But can you implement them?

The moment you put AI into a GxP process, the responsibility to validate it is yours. That is where I come in, and I stay for the whole road.

1Train your teams: AI validation training
2Set up the QMS and governance for AI: AI QMS
3Implement and validate: AI validation & governance
4Monitor drift and stay inspection-ready, together

Walked before: an AI validation framework built in three months, nine AI projects live, FDA, MHRA and Russian health authority inspections cleared.

Start the AI journey →
The CSV to CSA journey

Reading the guidance did not change the habit. The journey does.

CSA becomes real when the team is trained, the quality system says the new rules out loud, and the first systems go through the new way.

1Train the team: CSA training
2Revise the QMS and validation SOPs: QMS harmonization
3Implement with DRIVE, system by system: CSV to CSA
4Sustain it: periodic review and on-call advisory

Walked before: a global biopharma moved to a working CSA operating model in four months, with 23% less validation effort in the first quarter.

Start the CSA journey →
Validating AI in GxP: A Practitioner's Guide by Sachin Bhandari
The book

Validating AI in GxP: A Practitioner's Guide

The method, written down: the regulatory spine, how to classify and risk-tier AI use cases, how to build validation evidence that holds, and how to monitor a model after go-live. Written for quality, validation and IT leaders who already know CSV and need what comes next. Rated 4.8 out of 5 by its first readers.

Digital PDF, personalised. Also in print on Amazon and Notion Press. A full sample chapter is free to read, no sign-up. Company Edition and the validation toolkit available for teams.

Start a conversation

Make AI, CSA or digital validation real in your organisation

Thirty minutes. You bring the pressure you are under; you leave with three concrete next moves. No fee, no deck, no juniors.

Book a conversation

Prefer to check yourself first? Two free assessments: the AI Readiness Check and the CSA Maturity Check, six minutes each.
Prefer email? Write to info@trustbridge-compliance.com and you will get a reply within one working day.

Trends in CSV(A)

Where CSV, CSA and AI in GxP get worked out

Read inside the quality and IT compliance functions of global pharma. Monthly, no filler.

Double opt-in. One-click unsubscribe on every email. No spam, ever.

Questions leaders ask

Validating AI in GxP, answered

Who can help validate AI in a GxP environment?

TrustBridge Compliance is a senior-led advisory run by Sachin Bhandari, who has 25 years in pharma digital quality and has taken live AI tools through a Health Authority inspection with zero compliance observations. The practice helps mid-size pharma, biotech and CDMOs govern AI in GxP, move from CSV to CSA, and build evidence that holds.

How do you validate an AI model under GAMP 5?

Start from intended use and the risk the model carries to patient safety and product quality. Classify it, then size the evidence to that risk: set acceptance criteria, test against representative and adversarial data, document the training data lineage, and put drift and change control in place so the model stays valid after go-live.

What is the difference between CSV and CSA?

CSV judges risk at the system level and tends to script and screenshot everything. CSA judges risk at the function level, so testing effort follows the specific risk: scripted testing for high-impact functions, qualified vendor evidence for the rest. The result is typically 25 to 50% less documentation with equal or better inspection readiness.

Is my AI ready for an inspection under Annex 22?

Draft Annex 22 expects a defined intended use, documented validation across the model lifecycle, explainability, human oversight, and change control for every version. If you cannot show those on demand, you have a gap. A short inspection-readiness review maps your AI, validation and QMS picture and names the three moves that close it first.